Researchers develop vaccine to fight opioid misuse, addiction

Immunizations for the flu, smallpox and polio are essential in protecting against dangerous diseases. Now, widespread opioid addiction has pushed researchers to develop a vaccine against the effects of overdose and misuse.

According to results presented at the National Meeting & Exposition of the American Chemical Society (ACS), researchers are developing a vaccine against the growing threat of opioid addiction. The vaccine was developed to prevent opioid receptors in the body from attaching to antibodies, a method that involved the linking together of the opioid molecules which are normally too small to block.

"There is an urgent need to discover effective medications to treat substance use disorders. Increasingly, drug users are turning to opioids and powerful synthetic versions of these drugs that can sometimes be as much as 100 times more potent than heroin," said Kim D. Janda, PhD, head of the vaccine research team.

Read the full story below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.